Chinese regulations fuel medical tourism abroad, but for how long?
Demand for care that patients trust is sending more Chinese travelers to hospitals overseas. Whether that lasts depends on how fast Beijing lets foreign providers in.
2 min read
Medical travel from China is growing fast, and its main driver is trust. Many patients doubt the quality of care at home, especially outside the largest cities, and they are willing to travel for treatment they believe is better. A report on medical travel by Ctrip put growth in the number of Chinese medical tourists at 500 percent in 2016, and the trend has continued through this year.
Many kinds of medical trip
The category is broad. Some travelers go abroad for thorough health checks and advanced cancer screening. Others travel to South Korea for cosmetic surgery. A growing number go for treatment of cancer and other serious illnesses, which can mean weeks or months near a hospital in the United States or elsewhere. Nor is the trend limited to the wealthy. Families of modest means also look abroad when care near home is poor or waiting lists are long, sometimes finding treatment that costs less as well as inspiring more confidence.
Why foreign hospitals stay outside
An obvious answer to that demand would be for well-known foreign hospitals to open in China. The rules make that slow, costly and uncertain. A proposal can take years to move from plan to approval, with large legal teams and budgets, and there is no guarantee of success at the end.
The experience of Landseed, a Taiwanese hospital group, shows the scale of the obstacle. Its hospital in Shanghai was one of the first foreign-owned hospitals on the mainland, and according to a report in the South China Morning Post it needed some 150 official seals and years of delays before it could open.
Other routes in
Some providers have chosen partnerships instead. In September, Sir Run Run Shaw Hospital in Hangzhou, affiliated with Zhejiang University’s medical school, joined the Mayo Clinic Care Network, the first hospital from China to do so. Membership gives doctors access to Mayo’s specialists and resources without Mayo owning anything in China. At the same time Mayo receives Chinese patients in the United States, many arriving through agencies that arrange the whole trip.
Investors are also testing the market. This week Ping An Capital, part of the Ping An insurance group, led an investment of 800 million yuan, about $121 million, in Fullerton Health, a Singapore-based healthcare company that plans to open around 100 clinics in large Chinese cities such as Beijing, Shanghai and Guangzhou.
Will demand move back home?
Deals like these suggest that China is gradually opening to more foreign healthcare providers. If clinics with international standards become common in Chinese cities, some patients who now fly abroad for checkups may stay at home.
For now, the effect is likely to be small. The approval process remains slow, any new foreign-linked clinics will take years to build a reputation, and demand for care that patients trust is rising faster than supply. Treatment for serious illness, in particular, will keep drawing patients to hospitals abroad. For providers overseas, Chinese medical travel looks set to keep growing for some time, and those who manage to establish operations inside China will find a large market there too.